CN104888120A - Traditional Chinese medicine for preventing psoriasis vulgaris from relapse - Google Patents
Traditional Chinese medicine for preventing psoriasis vulgaris from relapse Download PDFInfo
- Publication number
- CN104888120A CN104888120A CN201510316488.3A CN201510316488A CN104888120A CN 104888120 A CN104888120 A CN 104888120A CN 201510316488 A CN201510316488 A CN 201510316488A CN 104888120 A CN104888120 A CN 104888120A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- fructus
- chinese medicine
- isatidis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention belongs to the technical field of the medicines and particularly relates to a traditional Chinese medicine for preventing psoriasis vulgaris from relapse. The traditional Chinese medicine is prepared from the following traditional Chinese medicine raw materials: 22-38 parts of unprocessed rehmannia roots, 8-16 parts of tree peony bark, 8-16 parts of red peony roots, 8-16 parts of scrophularia ningpoensis, 8-16 parts of radix isatidis, 4-8 parts of andrographis paniculata, 5-13 parts of folium isatidis, 8-16 parts of wild chrysanthemum, 11-19 parts of rhizoma smilacis glabrae, 8-16 parts of lightyellow sophora root, 8-16 parts of cortex dictamni, 5-13 parts of cnidium monnieri, 8-16 parts of fructus kochiae, 5-13 parts of divaricate saposhnikovia roots, 8-16 parts of Chinese thorowax roots, 5-13 parts of pericarpium citri reticulatae viride, 8-16 parts of cyperus rotundus, 5-13 parts of Szechwan chinaberry fruit, 5-13 parts of citrus medica, 5-13 parts of fructus citri, 4-8 parts of rose flowers, 5-13 parts of turmeric root-tuber, 8-16 parts of angelica sinensis, 8-16 parts of white paeony roots, 6-14 parts of codonopsis pilosula and 6-14 parts of astragalus membranaceus. The traditional Chinese medicine provided by the invention has the advantages as follows: the psychological status of cured patients with psoriasis vulgaris is improved, the recurrence rate of the patients is reduced, the skin lesion area and severity after relapse are alleviated, concomitant symptoms are reduced and living quality is improved.
Description
Technical field
The invention belongs to medical art, be specifically related to a kind of Chinese medicine preventing psoriasis vulgaris to recur.
Background technology
Psoriasis (Psorasis) is also called psoriasis, is clinical common chronic recurrent inflammatory dermatoses.After psoriasis clinical cure, relapse rate is higher is current comparatively stubborn problem.Traditional Chinese Medicine has unique advantage in control psoriasis, thinks that its pathogenesis is main relevant with " heat in blood ", therefore clinically gives removing pathogenic heat from blood and toxic substance from the body chemoprophylaxis or postpone it to recur more.In recent years, psoriasis obtains clinical extensive accreditation as the chronic somatopsychic illness of one, its coincident with severity degree of condition and mental status in close relations, consistent with the theory that Mental causes a disease, Chinese medicine thinks feelings will internal injury, obstruction of QI, Yu Huahuo of a specified duration, hematozemia impairment of YIN, failure of skin and muscle to be nourished is sent out as psoriasis.Psoriasis Problems Concerning Their Recurrence is the main bugbear that clinic skin section faces.For psoriatic preventing and controlling, there is important clinical meaning.Exploration side effect is little and cost-effective anti-recurrence means have very important society and clinical value.
Summary of the invention
Technical problem to be solved by this invention avoids the weak point existing for above-mentioned prior art, a kind of Chinese medicine preventing psoriasis vulgaris to recur is provided, this Chinese medicine has the psychologic status of the patients with psoriasis vulgaris can improving clinical cure, reduce the relapse rate of patient, alleviate the rear skin lesion area of recurrence and the order of severity, reduce simultaneous phenomenon, advantage of improving the quality of living.
The present invention is achieved through the following technical solutions:
Prevent the Chinese medicine that psoriasis vulgaris recurs, be made up of the raw material of Chinese medicine medicine of following weight portion:
Radix Rehmanniae 22-38 part, Cortex Moutan 8-16 part, Radix Paeoniae Rubra 8-16 part, Radix Scrophulariae 8-16 part, Radix Isatidis 8-16 part, Radix Isatidis 8-16 part, Herba Andrographis 4-8 part, Folium Isatidis 5-13 part, Flos Chrysanthemi Indici 8-16 part, Rhizoma Smilacis Glabrae 11-19 part, Radix Sophorae Flavescentis 8-16 part, Cortex Dictamni 8-16 part, Fructus Cnidii 5-13 part, Fructus Kochiae 8-16 part, Radix Saposhnikoviae 5-13 part, Radix Bupleuri 8-16 part, Pericarpium Citri Reticulatae Viride 5-13 part, Rhizoma Cyperi 8-16 part, Fructus Toosendan 5-13 part, Fructus Citri Sarcodactylis 5-13 part, Fructus Citri 5-13 part, Flos Rosae Rugosae 4-8 part, Radix Curcumae 5-13 part, Radix Angelicae Sinensis 8-16 part, Radix Paeoniae Alba 8-16 part, Radix Codonopsis 6-14 part, Radix Astragali 6-14 part.
Preferably, the Chinese medicine of above-mentioned prevention psoriasis vulgaris recurrence, be made up of the raw material of Chinese medicine medicine of following weight portion:
Radix Rehmanniae 26-34 part, Cortex Moutan 10-14 part, Radix Paeoniae Rubra 10-14 part, Radix Scrophulariae 10-14 part, Radix Isatidis 10-14 part, Radix Isatidis 10-14 part, Herba Andrographis 5-7 part, Folium Isatidis 7-11 part, Flos Chrysanthemi Indici 10-14 part, Rhizoma Smilacis Glabrae 13-17 part, Radix Sophorae Flavescentis 10-14 part, Cortex Dictamni 10-14 part, Fructus Cnidii 7-11 part, Fructus Kochiae 10-14 part, Radix Saposhnikoviae 7-11 part, Radix Bupleuri 10-14 part, Pericarpium Citri Reticulatae Viride 7-11 part, Rhizoma Cyperi 10-14 part, Fructus Toosendan 7-11 part, Fructus Citri Sarcodactylis 7-11 part, Fructus Citri 7-11 part, Flos Rosae Rugosae 5-7 part, Radix Curcumae 7-11 part, Radix Angelicae Sinensis 10-14 part, Radix Paeoniae Alba 10-14 part, Radix Codonopsis 8-12 part, Radix Astragali 8-12 part.
Preferred, the Chinese medicine of above-mentioned prevention psoriasis vulgaris recurrence, be made up of the raw material of Chinese medicine medicine of following weight portion: Radix Rehmanniae 30 parts, Cortex Moutan 12 parts, Radix Paeoniae Rubra 12 parts, Radix Scrophulariae 12 parts, Radix Isatidis 12 parts, Radix Isatidis 12 parts, Herba Andrographis 6 parts, Folium Isatidis 9 parts, Flos Chrysanthemi Indici 12 parts, Rhizoma Smilacis Glabrae 15 parts, Radix Sophorae Flavescentis 12 parts, Cortex Dictamni 12 parts, Fructus Cnidii 9 parts, the Fructus Kochiae 12 parts, Radix Saposhnikoviae 9 parts, Radix Bupleuri 12 parts, 9 parts, Pericarpium Citri Reticulatae Viride, Rhizoma Cyperi 12 parts, Fructus Toosendan 9 parts, Fructus Citri Sarcodactylis 9 parts, Fructus Citri 9 parts, Flos Rosae Rugosae 6 parts, Radix Curcumae 9 parts, Radix Angelicae Sinensis 12 parts, the Radix Paeoniae Alba 12 parts, Radix Codonopsis 10 parts, the Radix Astragali 10 parts.
The ratio of above weight proportion is through that science screening obtains, and for especial patient, as serious symptom or mild, fat or modest patient, can the proportioning of amount of corresponding adjustment composition, and increase or reduce being no more than 100%, drug effect is substantially constant.
The weight portion of said medicine, if in units of g, the normally consumption of 1 dose.
Chinese medicine of the present invention recurs for preventing psoriasis vulgaris.
Psoriasis is belonged to the sick category such as " white arrange ", " stubborn dermatitis " by Chinese medicine, think that its pathogenesis is based on " heat in blood ", and cause heat in blood to be mainly divided into exopathogenic factor and endogenous cause of ill, exopathogenic factor mainly poison evil in diseases caused by exogenous pathogenic factor six climate exopathogens is relevant, main and the internal injury caused by excess of seven emotions of endogenous cause of ill, improper diet and innate deficiency relevant; Inside and outside heresy causes obstruction of QI, strongly fragrant fire-transformation of a specified duration, and heat enters nutrient blood, with the passing of time dryness-transformation hematozemia impairment of YIN, failure of skin and muscle to be nourished and falling ill.Modern medicine thinks that psoriasis is a kind of chronic somatopsychic illness, basically identical with the principle of Chinese medicine emotion pathopoiesis.Psychological stimulation affects autonomic nervous function by nervus centralis, and then affects hormonal system and immunologic function, thus causes psoriasis occur or increase the weight of.The traditional Chinese medical science thinks feelings will internal injury, and obstruction of QI, Yu Huahuo of a specified duration, hematozemia impairment of YIN, failure of skin and muscle to be nourished is sent out as psoriasis.
The Chinese herb on the prevention psoriasis recurrence of prevention psoriasis vulgaris of the present invention recurrence, in side Radix Rehmanniae, Cortex Moutan, Radix Paeoniae Rubra, Radix Scrophulariae merit with clearing away heat,cooling blood and removing toxin altogether for monarch drug; Radix Isatidis, Radix Isatidis, Herba Andrographis, Folium Isatidis, Flos Chrysanthemi Indici merit are with heat-clearing and toxic substances removing; Radix Bupleuri, Pericarpium Citri Reticulatae Viride, Rhizoma Cyperi, Fructus Toosendan, Fructus Citri Sarcodactylis, Fructus Citri, Flos Rosae Rugosae, Radix Curcumae merit, with dispersing the stagnated live-QI to relieve the stagnation of QI, are ministerial drug altogether; Radix Angelicae Sinensis, Radix Paeoniae Alba merit are with yin nourishing of enriching blood, and Radix Codonopsis, Radix Astragali merit are with air making-up and spleen enlivening, and four medicines consolidate righting, are adjuvant drug altogether; Rhizoma Smilacis Glabrae, Radix Sophorae Flavescentis, Cortex Dictamni, Fructus Cnidii, the Fructus Kochiae, Radix Saposhnikoviae merit with dispeiling pathogenic wind and removing dampness, treat tinea and relieving itching, altogether for making medicine; All medicines share, and play the effect of clearing away heat,cooling blood and removing toxin, dispersing the stagnated live-QI to relieve the stagnation of QI, strengthening the body resistance, treatment tinea and relieving itching altogether.This research is linked closely the basic pathogenesis of psoriasis " heat in blood ", clearing away heat,cooling blood and removing toxin, treat tinea and relieving itching while, consolidate righting, healthy energy foot then heresy can not be done; Psoriasis as a kind of somatopsychic illness, is taken into full account that mental status is on psoriatic impact, reuses depressed liver-energy dispersing and QI regulating resolving depression medicine by this research simultaneously, meets the pathogenesis that Mental causes a disease.
Chinese medicine of the present invention can improve the psychologic status of the patients with psoriasis vulgaris of clinical cure, reduces the relapse rate of patient, alleviates the rear skin lesion area of recurrence and the order of severity, reduces simultaneous phenomenon, improve the quality of living; Consistent with the society-psychology-medical model of modern medicine, also embody the traditional Chinese medical science " preventive treatment of disease " theoretical, clinic is applied.
Detailed description of the invention
Below in conjunction with specific embodiment, the present invention is further described, so that those skilled in the art more understands the present invention, but does not therefore limit the present invention.
Embodiment 1
Prevent the Chinese medicine that psoriasis vulgaris recurs, each crude drug weight proportion is as follows:
Radix Rehmanniae 30g, Cortex Moutan 12g, Radix Paeoniae Rubra 12g, Radix Scrophulariae 12g, Radix Isatidis 12g, Radix Isatidis 12g, Herba Andrographis 6g, Folium Isatidis 9g, Flos Chrysanthemi Indici 12g, Rhizoma Smilacis Glabrae 15g, Radix Sophorae Flavescentis 12g, Cortex Dictamni 12g, Fructus Cnidii 9g, Fructus Kochiae 12g, Radix Saposhnikoviae 9g, Radix Bupleuri 12g, Pericarpium Citri Reticulatae Viride 9g, Rhizoma Cyperi 12g, Fructus Toosendan 9g, Fructus Citri Sarcodactylis 9g, Fructus Citri 9g, Flos Rosae Rugosae 6g, Radix Curcumae 9g, Radix Angelicae Sinensis 12g, Radix Paeoniae Alba 12g, Radix Codonopsis 10g, Radix Astragali 10g.
Embodiment 2
Prevent the Chinese medicine that psoriasis vulgaris recurs, each crude drug weight proportion is as follows:
Radix Rehmanniae 26g, Cortex Moutan 14g, Radix Paeoniae Rubra 10g, Radix Scrophulariae 14g, Radix Isatidis 10g, Radix Isatidis 14g, Herba Andrographis 5g, Folium Isatidis 11g, Flos Chrysanthemi Indici 10g, Rhizoma Smilacis Glabrae 17g, Radix Sophorae Flavescentis 10g, Cortex Dictamni 14g, Fructus Cnidii 7g, Fructus Kochiae 14g, Radix Saposhnikoviae 7g, Radix Bupleuri 14g, Pericarpium Citri Reticulatae Viride 7g, Rhizoma Cyperi 14g, Fructus Toosendan 7g, Fructus Citri Sarcodactylis 11g, Fructus Citri 7g, Flos Rosae Rugosae 7g, Radix Curcumae 7g, Radix Angelicae Sinensis 14g, Radix Paeoniae Alba 10g, Radix Codonopsis 12g, Radix Astragali 8g.
Embodiment 3
Prevent the Chinese medicine that psoriasis vulgaris recurs, each crude drug weight proportion is as follows:
Radix Rehmanniae 34g, Cortex Moutan 10g, Radix Paeoniae Rubra 14g, Radix Scrophulariae 10g, Radix Isatidis 14g, Radix Isatidis 10g, Herba Andrographis 7g, Folium Isatidis 7g, Flos Chrysanthemi Indici 14g, Rhizoma Smilacis Glabrae 13g, Radix Sophorae Flavescentis 14g, Cortex Dictamni 10g, Fructus Cnidii 11g, Fructus Kochiae 10g, Radix Saposhnikoviae 11g, Radix Bupleuri 10g, Pericarpium Citri Reticulatae Viride 11g, Rhizoma Cyperi 10g, Fructus Toosendan 11g, Fructus Citri Sarcodactylis 7g, Fructus Citri 11g, Flos Rosae Rugosae 5g, Radix Curcumae 11g, Radix Angelicae Sinensis 10g, Radix Paeoniae Alba 14g, Radix Codonopsis 8g, Radix Astragali 12g.
Embodiment 4
Prevent the Chinese medicine that psoriasis vulgaris recurs, each crude drug weight proportion is as follows:
Radix Rehmanniae 22g, Cortex Moutan 16g, Radix Paeoniae Rubra 8g, Radix Scrophulariae 16g, Radix Isatidis 8g, Radix Isatidis 16g, Herba Andrographis 4g, Folium Isatidis 13g, Flos Chrysanthemi Indici 8g, Rhizoma Smilacis Glabrae 19g, Radix Sophorae Flavescentis 8g, Cortex Dictamni 16g, Fructus Cnidii 5g, Fructus Kochiae 16g, Radix Saposhnikoviae 5g, Radix Bupleuri 16g, Pericarpium Citri Reticulatae Viride 5g, Rhizoma Cyperi 16g, Fructus Toosendan 5g, Fructus Citri Sarcodactylis 13g, Fructus Citri 5g, Flos Rosae Rugosae 8g, Radix Curcumae 5g, Radix Angelicae Sinensis 16g, Radix Paeoniae Alba 8g, Radix Codonopsis 14g, Radix Astragali 6g.
Embodiment 5
Prevent the Chinese medicine that psoriasis vulgaris recurs, each crude drug weight proportion is as follows:
Radix Rehmanniae 38g, Cortex Moutan 8g, Radix Paeoniae Rubra 16g, Radix Scrophulariae 8g, Radix Isatidis 16g, Radix Isatidis 8g, Herba Andrographis 8g, Folium Isatidis 5g, Flos Chrysanthemi Indici 16g, Rhizoma Smilacis Glabrae 11g, Radix Sophorae Flavescentis 16g, Cortex Dictamni 8g, Fructus Cnidii 13g, Fructus Kochiae 8g, Radix Saposhnikoviae 13g, Radix Bupleuri 8g, Pericarpium Citri Reticulatae Viride 13g, Rhizoma Cyperi 8g, Fructus Toosendan 13g, Fructus Citri Sarcodactylis 5g, Fructus Citri 13g, Flos Rosae Rugosae 4g, Radix Curcumae 13g, Radix Angelicae Sinensis 8g, Radix Paeoniae Alba 16g, Radix Codonopsis 6g, Radix Astragali 14g.
Carried out clinical pharrnacokinetics test to the Chinese medicine of embodiments of the invention l, Details as Follows:
1.1 physical data
Choose patients with psoriasis vulgaris 100 example reaching clinical cure.Inclusive criteria: (1) psoriasis vulgaris diagnosis doctor trained in Western medicine meets " skin cypridology "; (2) first attack clinical cure: skin lesion disappears substantially, clinical symptom disappearance, PAI marks minimizing 95%; (3) 18 years old < age <75 year; (4) this research is added voluntarily; Exclusion standard: (1) other types psoriasis; (2) serious cardiopulmonary hepatic and kidney function obstacle person is merged; (3) gestation or women breast-feeding their children; (4) with mental sickness person; (5) researcher can not be coordinated.
1.2 method
1.2.1 Therapeutic Method
Give prevention of the present invention psoriatic Chinese medicine, prescription is as follows: Radix Rehmanniae 30g, Cortex Moutan 12g, Radix Paeoniae Rubra 12g, Radix Scrophulariae 12g, Radix Isatidis 12g, Radix Isatidis 12g, Herba Andrographis 6g, Folium Isatidis 9g, Flos Chrysanthemi Indici 12g, Rhizoma Smilacis Glabrae 15g, Radix Sophorae Flavescentis 12g, Cortex Dictamni 12g, Fructus Cnidii 9g, Fructus Kochiae 12g, Radix Saposhnikoviae 9g, Radix Bupleuri 12g, Pericarpium Citri Reticulatae Viride 9g, Rhizoma Cyperi 12g, Fructus Toosendan 9g, Fructus Citri Sarcodactylis 9g, Fructus Citri 9g, Flos Rosae Rugosae 6g, Radix Curcumae 9g, Radix Angelicae Sinensis 12g, Radix Paeoniae Alba 12g, Radix Codonopsis 10g, Radix Astragali 10g; Be decocted in water for oral dose, every day potion, sooner or later sub-service, within 2 months, be a course for the treatment of, winter and spring respectively uses a course for the treatment of.
1.2.2 follow-up observation
Patient's recurrence and psychologic situation after 3 years is treated in follow-up observation;
Recurrence comprises: relapse rate (recurrence criterion: new erythra appears in clinical cure patient, and PASI scoring increase >=1), skin lesion area and the order of severity (PASI) and traditional Chinese medical science simultaneous phenomenon (dry mouth and tougue, large dry stool, yellowish or reddish urine, red tongue, yellow fur, stringy pulse or number);
Psychologic status comprises: Analysisof Self-rating Anxiety Scale (SAS) scoring, self rating depressive scale (SDS) scoring, Self-reporting inventory (SCL-90) scoring and dermatology life quality index (DLQI) scoring.
2. result
2.1 follow up a case by regular visits to 3 years recurrences compares
100 routine follow-up of patients, 3 years relapse rates are 5.0%(5/100), PASI scoring is (3.22 ± 0.16) point, and every traditional Chinese medical science simultaneous phenomenon incidence rate, in table 1.
The routine follow-up of patients of table 1 100 3 years traditional Chinese medical science simultaneous phenomenon incidence rates
| Number of cases | Time | Dry mouth and tougue | Yellowish or reddish urine | Large dry stool | Red tongue | Yellow fur | Stringy pulse or number |
| 100 examples | Follow up a case by regular visits to 3 years | 5（5.0%） | 6（6.0%） | 7（7.0%） | 5（5.0%） | 6（6.0%） | 4（4.0%） |
2.2 follow up a case by regular visits to 3 years psychologic statuses and quality of life
The 100 routine follow-up of patients SAS of 3 years marks, SDS marks, SCL-90 marks and DLQI scoring (P<0.05); In table 2.
Table 2 follows up a case by regular visits to 3 years psychologic statuses and quality of life
| Number of cases | Time | SAS marks | SDS marks | SCL-90 marks | DLQI marks |
| 100 examples | Follow up a case by regular visits to 3 years | 12.15±2.02 | 10.26±1.33 | 10.14±2.67 | 3.34±1.14 |
Claims (3)
1. prevent the Chinese medicine that psoriasis vulgaris recurs, be made up of the raw material of Chinese medicine medicine of following weight portion:
Radix Rehmanniae 22-38 part, Cortex Moutan 8-16 part, Radix Paeoniae Rubra 8-16 part, Radix Scrophulariae 8-16 part, Radix Isatidis 8-16 part, Radix Isatidis 8-16 part, Herba Andrographis 4-8 part, Folium Isatidis 5-13 part, Flos Chrysanthemi Indici 8-16 part, Rhizoma Smilacis Glabrae 11-19 part, Radix Sophorae Flavescentis 8-16 part, Cortex Dictamni 8-16 part, Fructus Cnidii 5-13 part, Fructus Kochiae 8-16 part, Radix Saposhnikoviae 5-13 part, Radix Bupleuri 8-16 part, Pericarpium Citri Reticulatae Viride 5-13 part, Rhizoma Cyperi 8-16 part, Fructus Toosendan 5-13 part, Fructus Citri Sarcodactylis 5-13 part, Fructus Citri 5-13 part, Flos Rosae Rugosae 4-8 part, Radix Curcumae 5-13 part, Radix Angelicae Sinensis 8-16 part, Radix Paeoniae Alba 8-16 part, Radix Codonopsis 6-14 part, Radix Astragali 6-14 part.
2. the Chinese medicine of prevention psoriasis vulgaris recurrence according to claim 1, is characterized in that, be made up of the raw material of Chinese medicine medicine of following weight portion:
Radix Rehmanniae 26-34 part, Cortex Moutan 10-14 part, Radix Paeoniae Rubra 10-14 part, Radix Scrophulariae 10-14 part, Radix Isatidis 10-14 part, Radix Isatidis 10-14 part, Herba Andrographis 5-7 part, Folium Isatidis 7-11 part, Flos Chrysanthemi Indici 10-14 part, Rhizoma Smilacis Glabrae 13-17 part, Radix Sophorae Flavescentis 10-14 part, Cortex Dictamni 10-14 part, Fructus Cnidii 7-11 part, Fructus Kochiae 10-14 part, Radix Saposhnikoviae 7-11 part, Radix Bupleuri 10-14 part, Pericarpium Citri Reticulatae Viride 7-11 part, Rhizoma Cyperi 10-14 part, Fructus Toosendan 7-11 part, Fructus Citri Sarcodactylis 7-11 part, Fructus Citri 7-11 part, Flos Rosae Rugosae 5-7 part, Radix Curcumae 7-11 part, Radix Angelicae Sinensis 10-14 part, Radix Paeoniae Alba 10-14 part, Radix Codonopsis 8-12 part, Radix Astragali 8-12 part.
3. the Chinese medicine of prevention psoriasis vulgaris recurrence according to claim 2, it is characterized in that, the described raw material of Chinese medicine medicine by following weight portion is made:
Radix Rehmanniae 30 parts, Cortex Moutan 12 parts, Radix Paeoniae Rubra 12 parts, Radix Scrophulariae 12 parts, Radix Isatidis 12 parts, Radix Isatidis 12 parts, Herba Andrographis 6 parts, Folium Isatidis 9 parts, Flos Chrysanthemi Indici 12 parts, Rhizoma Smilacis Glabrae 15 parts, Radix Sophorae Flavescentis 12 parts, Cortex Dictamni 12 parts, Fructus Cnidii 9 parts, the Fructus Kochiae 12 parts, Radix Saposhnikoviae 9 parts, Radix Bupleuri 12 parts, 9 parts, Pericarpium Citri Reticulatae Viride, Rhizoma Cyperi 12 parts, Fructus Toosendan 9 parts, Fructus Citri Sarcodactylis 9 parts, Fructus Citri 9 parts, Flos Rosae Rugosae 6 parts, Radix Curcumae 9 parts, Radix Angelicae Sinensis 12 parts, the Radix Paeoniae Alba 12 parts, Radix Codonopsis 10 parts, the Radix Astragali 10 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510316488.3A CN104888120A (en) | 2015-06-11 | 2015-06-11 | Traditional Chinese medicine for preventing psoriasis vulgaris from relapse |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510316488.3A CN104888120A (en) | 2015-06-11 | 2015-06-11 | Traditional Chinese medicine for preventing psoriasis vulgaris from relapse |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104888120A true CN104888120A (en) | 2015-09-09 |
Family
ID=54021361
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510316488.3A Pending CN104888120A (en) | 2015-06-11 | 2015-06-11 | Traditional Chinese medicine for preventing psoriasis vulgaris from relapse |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104888120A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006347985A (en) * | 2005-06-17 | 2006-12-28 | Ryukyu Bio Resource Kaihatsu:Kk | Medicinal composition containing crepidiastrum lanceolatum nakai and/or fermentation product of crepidiastrum lanceolatum nakai |
| CN1939498A (en) * | 2006-10-19 | 2007-04-04 | 王信锁 | Chinese-medicinal preparation for treating psoriasis |
-
2015
- 2015-06-11 CN CN201510316488.3A patent/CN104888120A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006347985A (en) * | 2005-06-17 | 2006-12-28 | Ryukyu Bio Resource Kaihatsu:Kk | Medicinal composition containing crepidiastrum lanceolatum nakai and/or fermentation product of crepidiastrum lanceolatum nakai |
| CN1939498A (en) * | 2006-10-19 | 2007-04-04 | 王信锁 | Chinese-medicinal preparation for treating psoriasis |
Non-Patent Citations (1)
| Title |
|---|
| 杨志波: "《当代中医皮肤科临床家丛书-欧阳恒》", 31 October 2014 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20070059386A1 (en) | Modular system for novel Chinese herbal formulas | |
| CN101279016A (en) | Oral medicament for curing craniocerebral injury associated with hydrocephalus | |
| CN103751562B (en) | A kind of Chinese medicine for the treatment of calculus | |
| CN102512617B (en) | Chinese herbal preparation for treating psoriasis | |
| CN103356968B (en) | Traditional Chinese medicine composition for treating endometriosis | |
| CN104435686A (en) | Use of traditional Chinese medicine preparation in preparation of medicine for treating skin itch and eczema papulosum | |
| CN104491733A (en) | Application of traditional Chinese medicine preparation in preparation of medicines for treating anemia, deficiency of vital energy and debilitation | |
| CN102988886A (en) | Chinese medicament for treating obesity | |
| CN104225507A (en) | Chinese medicine for treating limb paralysis and pain caused by cerebral hemorrhage | |
| CN108392556A (en) | The Chinese medicine of antipruritic anti-inflammatory, topical agent and preparation method thereof | |
| CN103893502A (en) | Traditional Chinese medicine for treating phlyctenular conjunctivitis | |
| CN104888120A (en) | Traditional Chinese medicine for preventing psoriasis vulgaris from relapse | |
| CN102225118A (en) | Blood-activating wind-dispelling liquid | |
| CN108295168B (en) | Traditional Chinese medicine composition for treating post-stroke depression | |
| CN103127444A (en) | Phlegm-qi stagnation type psychosis treatment traditional Chinese medicine | |
| CN105597030A (en) | Traditional Chinese medicine composition with functions of dispersing blood stasis and dredging vessels | |
| CN104258245A (en) | Traditional Chinese medicine composition for treating frequent micturition | |
| CN104721545A (en) | Traditional Chinese medicine composition for treating acne | |
| CN104825925A (en) | Traditional Chinese medicine for treating leukorrhagia | |
| CN104857449A (en) | Traditional Chinese medicine for curing infertility | |
| CN104771516A (en) | Traditional Chinese medicine composition for treating allergic dermatitis | |
| CN101062364B (en) | Medicine for treating canine distemper disease | |
| CN103071079A (en) | Traditional Chinese medicinal composition for treating prurigo nodularis | |
| CN106492163A (en) | A kind of Chinese medicine preparation for treating the vomiting of pregnancy | |
| CN105796989A (en) | Traditional Chinese medicine composition for treating leukemia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150909 |
|
| WD01 | Invention patent application deemed withdrawn after publication |